Ignite Creation Date:
2024-05-06 @ 8:18 PM
Last Modification Date:
2024-10-26 @ 3:24 PM
Study NCT ID:
NCT06321250
Status:
RECRUITING
Last Update Posted:
2024-07-09
First Post:
2024-03-14
Brief Title:
A Study of JMKX003948 Tablets in Patients With Renal Cell Carcinoma
Sponsor:
Jemincare
Organization:
Jemincare
Study Overview
Official Title:
An Open-label Multicenter Phase I Study to Evaluate the Safety Tolerability Pharmacokinetics and Preliminary Efficacy of JMKX003948 Tablets in Patients With Renal Cell Carcinoma
Status:
RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This open-label Phase 1 study will evaluate the safety tolerability PK characteristics and preliminarily efficacy of JMKX003948 tablets in patients with renal cell carcinoma
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None